logo
  

U.S. Government To Acquire 10 Mln Treatment Courses Of COVID-19 Antiviral Candidate From Pfizer

Pfizer Inc. (PFE) has agreed to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID, to the U.S. government. The agreement is subject to regulatory authorization from the FDA. Currently, the company is seeking Emergency Use Authorization of PAXLOVID with the FDA.

The U.S. government will acquire 10 million treatment courses beginning later in the year and concluding in 2022. Pfizer will receive $5.29 billion from the government, pending and contingent upon regulatory authorization.

"We were thrilled with the recent results of our phase 2/3 interim analysis, which showed overwhelming efficacy of PAXLOVID in reducing the risk of hospitalization among high-risk patients treated within three days of symptom onset by almost 90% and with no deaths," said Albert Bourla, CEO, Pfizer.

Pfizer noted that it has also entered into advance purchase agreements with several other countries and has started bilateral outreach to approximately 100 countries.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford Motor is increasing the entry-level price of its electric F-150 Lightning pickup citing rising costs and supply chain issues amid increasing demand. This is the second price hike after a recent increase in August. The starting price of the 2023 model year pickup will be raised by $5,000 by October 24, reports said citing an email statement. Constellation Brands, Inc. (STZ) said it delivered another quarter of strong business performance. Beer Business achieved double-digit net sales growth for the quarter, while Wine and Spirits net sales rose 1%. The solid top-line performance of its Beer and Wine and Spirits Businesses in the first half... Tyson Foods announced its "OneTyson" plan, under which it will bring together corporate team members from three corporate locations in Illinois and South Dakota to its world headquarters in Arkansas. Team members from the corporate locations of Chicago, Downers Grove in Illinois, and Dakota Dunes area in South Dakota are expected to begin the phased relocation in early 2023 to Springdale.
Follow RTT